Diagnosis, Pathology & Imaging
Understanding Biphasic Mesothelioma and Its Diagnostic Challenges
Biphasic mesothelioma contains epithelioid and sarcomatoid components. How pathologists identify it and why the mix affects prognosis and treatment.
pathology
Diagnosis, Pathology & Imaging
Serosal Reactions and Mesothelioma Diagnosis
How the pleura and peritoneum react to injury, why healing tissue can closely mimic mesothelioma, and how pathologists reliably tell the two apart.
Diagnosis, Pathology & Imaging
Malignant Mesothelioma: Diagnosis, Subtypes, and Challenges
The three main mesothelioma subtypes, how pathologists tell them apart, and why accurate subclassification changes prognosis and treatment planning.
Diagnosis, Pathology & Imaging
Sarcomatoid Mesothelioma: Diagnostic Challenges and Differentiation
Understanding the complexities of diagnosing and distinguishing sarcomatoid mesothelioma from other spindle cell tumors.
Diagnosis, Pathology & Imaging
Mesothelioma Histology: Diagnosing Malignancy with Confidence
Why mesothelioma is hard to diagnose under the microscope, which features separate benign reactions from malignancy, and where errors commonly occur.
Diagnosis, Pathology & Imaging
Epithelioid Mesothelioma: Diagnosis, Challenges, and Key Features
Epithelioid mesothelioma is the most common and most treatable subtype. How it is diagnosed and distinguished from adenocarcinoma and reactive change.
Diagnosis, Pathology & Imaging
Mesothelioma in Situ: The Earliest Stage of Mesothelioma
Mesothelioma in situ is the earliest recognised stage. How it is diagnosed, why it was only recently defined, and what it means for early treatment.
Diagnosis, Pathology & Imaging
Ancillary Studies in Mesothelioma Diagnosis: Distinguishing the Benign from the Malignant
Understanding ancillary studies in mesothelioma diagnosis and the role of immunohistochemistry, ploidy, and cytogenetics.
Diagnosis, Pathology & Imaging
Ancillary Studies in the Diagnosis of Mesothelioma
The role of ancillary studies in differentiating mesothelioma from adenocarcinoma using histochemistry, immunohistochemistry, and electron microscopy.
Page 1 of 2